Using Ghrelin mRNA for the Smart Targeting of Damaged Joints In a step toward disease-modifying therapy, Tufts researchers and collaborators have pioneered nanoparticles that target damaged cartilage and adapt to disease severity.
Tufts Vice Provost for Research Named Foreign Fellow of Indian National Science Academy Bernard Arulanandam’s research interests include the cellular and molecular mechanisms involved in immune responses to infectious diseases.
What Happens When Neighborhood Pharmacies Close School of Medicine experts explain pharmacy deserts and how consumers are impacted by thousands of shuttered drugstore locations.
Breaking Down the Layers of the Immune System A look at how the body’s multi-pronged defenses work, plus advice from an immunologist on how to strengthen them.
Immune Molecule Long Tied to Inflammation May Benefit the Aging Brain Study shows that STING, a molecule that some experimental drugs seek to block, may actually help protect the brain against Alzheimer’s-like decline.
New AI Tool Reveals How Drugs Kill Tuberculosis Tufts researchers’ approach uncovers how TB treatments can best work together at the cellular level to speed better cures.
Can Wastewater Surveillance Work Without Sewers? Study shows how places without modern sanitation systems can still use wastewater to catch outbreaks before dangerous diseases travel across borders.
A Transformative Leader for a New Era of Research at Tufts Dr. Iris Jaffe appointed inaugural director of the Tufts University–Tufts Medicine Research Enterprise.
Pneumonia Cases Are High. How to Protect Yourself and Your Child After a surge of pneumonia in 2024, a public health expert explains how to prevent, identify, and treat this common lung infection.